Navigation Links
For platinum catalysts, smaller may be better
Date:6/28/2010

>Says Salmeron, "The unanswered question today is what are the geometry and location of the catalyst atoms when the surfaces are covered with dense layers of molecules, as occurs during a chemical reaction."

Somorjai and Salmeron have for many years been collaborating on the development of instrumentation and techniques that enable them to do catalysis studies under realistic conditions. They now have at their disposal unique high-pressure scanning tunneling microscopes (STM) and an ambient pressure x-ray photoelectron spectroscopy (AP-XPS) beamline operating at the Berkeley Lab's Advanced Light Source, a premier source of synchrotron radiation for scientific research.

"With these two resources, we can image the atomic structure and identify the chemical state of catalyst atoms and adsorbed reactant molecules under industrial-type pressures and temperatures," Salmeron says.

STM images revealed the formation of nanoclusters on the platinum crystal surfaces, and the AP-XPS spectra revealed a change in carbon monoxide electron binding energies. A subsequent collaboration with Lin-Wang Wang, a theorist in Berkeley Lab's Computational Sciences Division, explained the change in structure as the result of the relaxation of the strong repulsion between carbon monoxide molecules that arises from their very high density on the surface when in equilibrium with elevated pressures of the gas.

"In the future, the use of these stable platinum nanoclusters as fuel cell catalysts may help to boost performance and reduce costs," Somorjai says.

The next step for Somorjai and Salmeron and their research team will be to determine whether other adsorbed reactants, such as oxygen or hydrogen, also result in the creation of nanoclusters in platinum. They also want to know if nanoclusters can be induced in other metal catalysts as well, such as palladium, silver, copper, rhodium, iron and cobalt.

"If this nanoclustering is a general phe
'/>"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
Source:Eurekalert  

Page: 1 2 3 4

Related biology technology :

1. Platinum-rich shell, platinum-poor core
2. First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs
3. Researchers create gold aluminum, black platinum, blue silver
4. UCT Specialties (Formerly Petrarch) Announces the Release of Their New Product Guides for Silanes, Silicones, Platinum Catalyst and Glass Coatings
5. BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008
6. Exiqon Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer
7. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
8. New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents
9. Boston Scientific Begins PLATINUM PLUS Trial for PROMUS(R) Element(TM) Stent System
10. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
11. Melting defects could lead to smaller, more powerful microchips
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
For platinum catalysts, smaller may be better
(Date:9/2/2015)... ... September 02, 2015 , ... Genedata, a leading provider of ... Genedata Screener ® version 13.0 at ELRIG Drug Discovery 2015. This latest version ... set of new capabilities. Screener now supports High Throughput Flow Cytometry (HT-Flow) and ...
(Date:9/1/2015)... , Sept. 1, 2015 Prostate ... death in American men. One in seven ... 233,000 new cases are diagnosed annually. That said, ... using a powerful new technique, MRI Fusion Biopsy, ... large cancer lesions, treating only the affected areas ...
(Date:9/1/2015)... MILWAUKEE , Sept. 1, 2015 ... Eric Floyd , Ph.D., MBA as Chief ... (DLSS).  In this newly created role, Dr. Floyd ... well as a portfolio of pre-commercial and post ... medical affairs and medical communications.  Dr. Floyd brings ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... diseases has been discovered by researchers at the Keck Graduate Institute and its ... untreatable diseases. , The findings were published online on August 27 by Scientific ...
Breaking Biology Technology:New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 2Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 3Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 2Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 3Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 4
... ... in Prima BioMed Ltd (ASX:PRR), an Australian Securities Exchange-listed oncology biotechnology company. KTA ... Investors, LLC on the transaction. A copy of Prima BioMed Ltd,s public announcement ... ...
... ... Dr. Rebecca Fitzgerald, known among her medical colleagues as the "Sculptra guru" here in the ... at this year,s 4 day SDEF Cosmetic Dermatology Seminar held in Santa Monica, Ca. ... Los Angeles, Ca (PRWEB) ...
... multiple times a day can be difficult for patients to ... 1 to 7 percent of the dose is actually absorbed ... PhD, director of the Laboratory for Biomaterials and Drug Delivery ... can gradually dispense a constant amount of medication to the ...
Cached Biology Technology:KTA Capital Advises SpringTree Global Investors on an AU$25.5 Million Investment in Prima BioMed Ltd 2Looking Older Than You Are May Have Little to Do With Wrinkles 2Looking Older Than You Are May Have Little to Do With Wrinkles 3A drug-dispensing contact lens 2
(Date:8/6/2015)... SAN JOSE, Calif. , Aug. 6, 2015 ... the leading developer of human interface solutions, today ... and TouchPad technologies on Windows 10. Microsoft leveraged ... fundamental to the operating system. ... and drivers are fully certified with Microsoft,s Precision ...
(Date:8/4/2015)... ALBANY, N.Y., Aug. 4, 2015  AMRI (NASDAQ: AMRI ) ... June 30, 2015. Highlights: , Second quarter ... increase from 2014 , Adjusted contract margins of ... EPS of $0.22, including a $0.05 decrease in EPS from royalties ... of $16 million "We are very pleased to ...
(Date:7/31/2015)... , Chine, 31 juillet 2015 La ... www.icg-10.org ) sera organisée par le BGI du ... Shenzhen en Chine. La ... son inauguration en 2006, l,ICG est devenue l,une ... le domaine des « omiques » et c,est aussi la ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
... the University of Toronto have designed a nanoscale ... anthrax toxin in animal and laboratory experiments. The ... be applied in designing potent therapeutics for a ... researchers. , Anthrax toxin, secreted by the anthrax ...
... Researchers at the University at Buffalo and the ... that two intracellular events, both stimulated by the ... mammals. , The broad implication of the findings ... sub-cellular underpinnings of mammalian behavior, according to the ...
... will receive up to $10.3 million to help develop a new ... arm. The Utah work is a key part of a U.S. ... the new device for soldiers and potentially others whose arms were ... to your thoughts, that allows you to feel both the outside ...
Cached Biology News:Anthrax inhibitor counteracts toxin, may lead to new therapeutics 2Anthrax inhibitor counteracts toxin, may lead to new therapeutics 3Manipulating single cell receptor alters animal behavior 2Manipulating single cell receptor alters animal behavior 3University of Utah to help build bionic arm 2University of Utah to help build bionic arm 3University of Utah to help build bionic arm 4University of Utah to help build bionic arm 5
... Pfx DNA Polymerase is ideal for ... downstream applications such as cloning and ... by a proprietary enzyme preparation containing ... with proofreading (3'Cut Site5' exonuclease) activity. ...
... This antibody is generated from rabbits immunized ... within aa 50~150 of human PLAU. Purified ... 0.09% (W/V) sodium azide. This antibody is ... eluted out with both high and low ...
...
Human interferon-beta (IFN-beta). Recognizes amino acids 30-47 of IFN-beta. No cross-reactivity with Human IFN-alpha or IFN-gamma....
Biology Products: